ZYME analyst estimates
Zymeworks (ZYME) analyst ratings, the average price target and its range, and every firm's latest call.
ZYME analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 27, 2026 | Truist Financial | Zymeworks (ZYME) PT Raised to $35 at Truist Securities | $35.00 |
| Oct 23, 2026 | Jefferies | Zymeworks price target raised to $52 from $50 at Jefferies | $52.00 |
| Oct 7, 2026 | Truist Financial | Zymeworks price target raised to $34 from $32 at Truist | $34.00 |
| Aug 26, 2026 | Deutsche Bank | Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on FDA Approval for Zani | $32.00 |
| Aug 26, 2026 | H.C. Wainwright | Zymeworks price target raised to $55 from $51 at H.C. Wainwright | $55.00 |
| Aug 7, 2026 | Wells Fargo | Zymeworks price target raised to $40 from $37 at Wells Fargo | $40.00 |
| Aug 7, 2026 | Stifel Nicolaus | Zymeworks price target lowered to $46 from $47 at Stifel | $46.00 |
| Aug 7, 2026 | Truist Financial | Zymeworks price target raised to $32 from $31 at Truist | $32.00 |
| Aug 5, 2026 | H.C. Wainwright | Zymeworks price target raised to $51 from $46 at H.C. Wainwright | $51.00 |
| Jul 7, 2026 | Truist Financial | Zymeworks price target raised to $31 from $28 at Truist | $31.00 |
| Jun 30, 2026 | Wells Fargo | Zymeworks price target raised to $37 from $34 at Wells Fargo | $37.00 |
| Jun 9, 2026 | Truist Financial | Truist Securities Assumes Zymeworks (ZYME) at Buy | $28.00 |
| Jun 3, 2026 | H.C. Wainwright | H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) | $46.00 |
| Mar 9, 2026 | Evercore ISI | Zymeworks price target raised to $48 from $33 at Evercore ISI | $48.00 |
| Dec 17, 2025 | Truist Financial | Zymeworks initiated with a Buy at Truist | $40.00 |
- 11 firms rate ZYME: 11 buy, 0 hold, 0 sell.
- The average price target is $43.33 from 6 analysts, from $32.00 to $55.00.
Updated 2026-11-03 00:01 UTC